Tag

AML Archives | Carevive - cancer care management & patient engagement tools

PostersResources

Understanding Barriers to Oral Medication Adherence in Adults with Acute Myeloid Leukemia (AML)

Authors:  Ashley Leak Bryant PhD, RN1 ; Ya-Ning Chan RN, MSN1 ; Jaime Richardson RN, BSN1; Matthew Foster, MD1 ; Debra Wujcik, PhD, RN2 1 The University of North Carolina at Chapel Hill School of Nursing; 2 North Carolina Cancer Hospital, Lineberger Comprehensive Cancer Center, Division of Hematology and Oncology, The University of North Carolina at Chapel Hill 3 Carevive…
Carevive
May 5, 2020
CME

Clinically Integrating Patient-Reported Outcomes into Acute Myeloid Leukemia Care Management

Release Date: 11/8/2019 Expiration Date: 11/9/2020 Physicians – Maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses – 1.2 contact hours (0.4 pharmacotherapy) The goal of this project is to identify the variety of symptoms relevant to patients receiving treatment for AML and test the electronic Patient Reported Outcomes (ePRO) tool in the clinical setting. A certified educational training…
Carevive
November 27, 2019
CME

What’s New in Acute Myelogenous Leukemia?

Release date: October 17, 2018 
Expiration date: October 16, 2019 Estimated time to complete activity: 0.75 hours Acute myelogenous leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit…
Carevive
October 17, 2018
CME

Geriatric Assessment in Older Patients with AML: Treatment Updates and Implications

Release date: October 17, 2018 
Expiration date: October 16, 2019 Estimated time to complete activity: 0.5 hours Acute myelogenous leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit…
Carevive
October 17, 2018
Resources

[On-Demand Video] Acute Myelogenous Leukemia: Treatment Updates and Implications for Older Patients

Note: This on-demand video is not available for CME/CNE credit. Acute myeloid leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit patients treated with intensive chemotherapy…
Carevive
July 25, 2018